Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 2
1968 1
1971 2
1972 2
1973 1
1974 3
1975 5
1976 7
1977 3
1978 4
1979 2
1981 1
1982 3
1983 3
1984 3
1985 1
1989 1
1990 1
1991 4
1993 4
1994 1
1995 2
1996 4
1997 3
1998 6
1999 6
2000 3
2001 10
2002 6
2003 14
2004 16
2005 12
2006 13
2007 14
2008 13
2009 10
2010 16
2011 19
2012 18
2013 17
2014 23
2015 15
2016 19
2017 10
2018 20
2019 18
2020 23
2021 31
2022 26
2023 35
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

437 results

Results by year

Filters applied: . Clear all
Page 1
Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial.
de Latour RP, Szer J, Weitz IC, Röth A, Höchsmann B, Panse J, Usuki K, Griffin M, Kiladjian JJ, de Castro CM, Nishimori H, Ajayi T, Al-Adhami M, Deschatelets P, Francois C, Grossi F, Risitano AM, Hillmen P. de Latour RP, et al. Among authors: al adhami m. Lancet Haematol. 2022 Sep;9(9):e648-e659. doi: 10.1016/S2352-3026(22)00210-1. Lancet Haematol. 2022. PMID: 36055332 Clinical Trial.
Pegcetacoplan controls hemolysis in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria.
Wong RSM, Navarro-Cabrera JR, Comia NS, Goh YT, Idrobo H, Kongkabpan D, Gómez-Almaguer D, Al-Adhami M, Ajayi T, Alvarenga P, Savage J, Deschatelets P, Francois C, Grossi F, Dumagay T. Wong RSM, et al. Among authors: al adhami m. Blood Adv. 2023 Jun 13;7(11):2468-2478. doi: 10.1182/bloodadvances.2022009129. Blood Adv. 2023. PMID: 36848639 Free PMC article. Clinical Trial.
Proproliferative function of adaptor protein GRB10 in prostate carcinoma.
Khan MI, Al Johani A, Hamid A, Ateeq B, Manzar N, Adhami VM, Lall RK, Rath S, Sechi M, Siddiqui IA, Choudhry H, Zamzami MA, Havighurst TC, Huang W, Ntambi JM, Mukhtar H. Khan MI, et al. Among authors: adhami vm. FASEB J. 2019 Mar;33(3):3198-3211. doi: 10.1096/fj.201800265RR. Epub 2018 Oct 31. FASEB J. 2019. PMID: 30379590 Free PMC article.
Wood Microfluidics.
Andar A, Hasan MS, Srinivasan V, Al-Adhami M, Gutierrez E, Burgenson D, Ge X, Tolosa L, Kostov Y, Rao G. Andar A, et al. Among authors: al adhami m. Anal Chem. 2019 Sep 3;91(17):11004-11012. doi: 10.1021/acs.analchem.9b01232. Epub 2019 Aug 13. Anal Chem. 2019. PMID: 31361950
Hypoxia driven glycation: Mechanisms and therapeutic opportunities.
Khan MI, Rath S, Adhami VM, Mukhtar H. Khan MI, et al. Among authors: adhami vm. Semin Cancer Biol. 2018 Apr;49:75-82. doi: 10.1016/j.semcancer.2017.05.008. Epub 2017 May 22. Semin Cancer Biol. 2018. PMID: 28546110 Free PMC article. Review.
ISPAD roving reporters 2020.
Marks BE, Harnois-Leblanc S, Ng SM, Perez-Garcia EM, Ahmad PO, Adhami S, Mandilou SVM, Yauch LM, Ehtisham S. Marks BE, et al. Among authors: adhami s. Pediatr Diabetes. 2021 Aug;22(5):834-838. doi: 10.1111/pedi.13233. Epub 2021 Jun 9. Pediatr Diabetes. 2021. PMID: 34109724 No abstract available.
A giant leap for womankind.
Valantine H, Travis E, El-Adhami W, Vernos I, Mosqueda L, Wayne E, Kearns-Zimmerman F, Bonefont L, Visweswariah SS, Akande-Sholabi W, Polka J. Valantine H, et al. Among authors: el adhami w. Nat Med. 2019 May;25(5):704-707. doi: 10.1038/s41591-019-0446-y. Nat Med. 2019. PMID: 31036882 No abstract available.
437 results